Status:
COMPLETED
Hesperidin and Diosmin Effect on Metabolic Syndrome
Lead Sponsor:
Beni-Suef University
Conditions:
Metabolic Syndrome and Diabetic Neuropathy
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The components of metabolic syndrome (MetS), particularly obesity and dyslipidemia, are linked to peripheral neuropathy (PN) among patients with diabetes or even without diabetes. Several studies reve...
Eligibility Criteria
Inclusion
- Type 2 diabetes adult patients who meet metabolic syndrome criteria and with diabetic neuropathy
Exclusion
- patients without any parameter of inclusion criteria
Key Trial Info
Start Date :
March 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 12 2021
Estimated Enrollment :
129 Patients enrolled
Trial Details
Trial ID
NCT05243238
Start Date
March 1 2020
End Date
November 12 2021
Last Update
February 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University
Al Fayyum, Egypt, 13556